Does ALEMTUZUMAB Cause Urinary retention? 100 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Urinary retention have been filed in association with ALEMTUZUMAB (Campath). This represents 0.7% of all adverse event reports for ALEMTUZUMAB.
100
Reports of Urinary retention with ALEMTUZUMAB
0.7%
of all ALEMTUZUMAB reports
5
Deaths
57
Hospitalizations
How Dangerous Is Urinary retention From ALEMTUZUMAB?
Of the 100 reports, 5 (5.0%) resulted in death, 57 (57.0%) required hospitalization, and 4 (4.0%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which ALEMTUZUMAB Alternatives Have Lower Urinary retention Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET